Open AccessRoutine HIV Test Results in 6 US Clinical Laboratories Using the Recommended Laboratory HIV Testing Algorithm With Geenius HIV 1/2 Supplemental Assay
Author(s) -
Laura G. Wesolowski,
Pollyanna R Chavez,
Ana Marı́a Cárdenas,
Alex Katayev,
Patricia Slev,
Alexandra Valsamakis,
Yun F. Wang,
Joseph D. Yao,
Caitlin Dougherty,
Laura Gillim-Ross,
Christopher Harmon,
Kevin P. Delaney
Publication year - 2020
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000001102
Subject(s) - medicine , nucleic acid test , antibody , human immunodeficiency virus (hiv) , indeterminate , antigen , virology , immunology , algorithm , disease , covid-19 , infectious disease (medical specialty) , computer science , mathematics , pure mathematics
Geenius HIV 1/2 Supplemental Assay (Geenius; Bio-Rad Laboratories) is the only Food and Drug Administration-approved HIV-1/HIV-2 antibody differentiation test for the second step in the HIV laboratory testing algorithm. We characterized the occurrence of true HIV-1 and HIV-2 infections as well as false results in 6 US clinical laboratories using Geenius.